Bradley McGregor

29PUBLICATIONS
271CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Jul 01, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

|Jan 26, 2026
ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer.

Ilana B Epstein, Adetolani Odogiyon, Stephanie Berg

|Jan 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.

Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund

Pageof 5

Frequent Collaborators

12 joint publications

Toni K Choueiri

9 joint publications

Rana R McKay

5 joint publications

Stephanie Berg

5 joint publications

Wanling Xie